[Federal Register Volume 83, Number 63 (Monday, April 2, 2018)]
[Notices]
[Pages 13986-13987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-06547]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment (CHACHSPT)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
and the Health Resources and Services Administration (HRSA), announce 
the following meeting for the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment (CHACHSPT). This meeting is 
open to the public, limited only by 100 room seating and 100 ports for 
audio phone lines. Time will be available for public comment. The 
public is welcome to submit written comments in advance of the meeting. 
Comments should be submitted in writing by email to the contact person 
listed below. The deadline for receipts is Monday, May 7, 2018. Persons 
who desire to make an oral statement, may request it at the time of the 
public comments period on May 9, 2018 at 4:15 p.m. EDT. This meeting is 
accessible by web conference: 1-877-603-4228, Participant code: 
42598858.

DATES: The meeting will be held on May 9, 2018, 8:30 a.m. to 5:00 p.m., 
EDT and May 10, 2018, 8:30 a.m. to 12:00 p.m., EDT.

ADDRESSES: CDC Corporate Square, Building 8, Conference Room 1-ABC, 8 
Corporate Boulevard, Atlanta, Georgia 30329.

FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee 
Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E-07, 
Atlanta, Georgia 30333, telephone (404) 639-8317; [email protected]

SUPPLEMENTARY INFORMATION: 
    Purpose: This committee is charged with advising the Director, CDC 
and the Administrator, HRSA, regarding activities related to prevention 
and control of HIV/AIDS, Viral Hepatitis and other STDs, the support of 
health care services to persons living with HIV/AIDS, and education of 
health professionals and the public about HIV/AIDS, Viral Hepatitis and 
other STDs.
    Matters To Be Considered: The agenda will include discussions on 
(1) HIV, Viral Hepatitis, and Sexually Transmitted Disease consequences 
of

[[Page 13987]]

the opioid crisis; (2) Perspectives on, and experiences with, syringe 
services program (SSP); (3) Continued discussion on HIV transmission 
risk in the context of Antiretroviral Therapy (ART) use and Viral 
Suppression (Treatment as Prevention or TasP); (4) Anti-bullying 
policies in schools; and (5) Updates from Workgroups. Agenda items are 
subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-06547 Filed 3-30-18; 8:45 am]
 BILLING CODE 4163-19-P